You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firms will work to accelerate the adoption of PierianDx's genomics platform for translating data into patient-specific diagnoses and treatments.
The firms will develop new business opportunities, exchange technical expertise, and integrate their software and hardware systems.
As part of a collaboration with Freenome, Institut Curie will look for correlations between circulating biomarkers and human response to cancer immunotherapies.
The university's researchers have developed a laboratory test that measures the body's response to infection in the blood, and can distinguish between bacterial and viral meningitis.
Under the collaboration, Invitae will gain access to Kew's 435-gene tumor profiling NGS panel and proprietary bioinformatics software.
The company will design and validate a test using its Exolution isolation kit, which can stratify and monitor patients in Intezyne's clinical trials of IT-139.
The companies are accelerating the pace of an existing collaboration with the goal of detecting SMA "2+0" carrier status.
The collaborative study includes testing urine samples from patients who have an increased risk for complicated urinary tract infections.
The firms said that they are integrating CTC isolation and analysis technologies to create a workflow that provides clinical insights to physicians.
FlowMetric said that by combining products, the partners will provide consumers with data security and the ability to govern how their personal information is shared, utilized, and monetized.